Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4

Photochemistry and Photobiology

Volumn 84, Issue 2, 2008, Pages 407-414

  Ke, Malcolm S ^a   Xue, Liang Yan ^a   Feyes, Denise K ^a   Azizuddin, Kashif ^a   Baron, Elma D ^a,b,c   McCormick, Thomas S ^a,b   Mukhtar, Hasan ^a,b,d   Panneerselvam, Ashok ^a   Schluchter, Mark D ^a,b   Cooper, Kevin D ^a,b,c   Oleinick, Nancy L ^a,b   Stevens, Seth R ^a,b,c,e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLE DERIVATIVE; PHTHALOCYANINE PC 4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; DRUG EFFECT; HUMAN; LEUKEMIA CELL LINE; PHOTOCHEMOTHERAPY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; HUMANS; INDOLES; JURKAT CELLS; PHOTOCHEMOTHERAPY;

EID: 41049116373     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2007.00278.x     Document Type: Article

References (34)

1. Dougherty, T. J. (2002) An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20, 3 7.
2. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan Q. Peng (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889 905.
3. Oleinick, N. L. H. H. Evans (1998) The photobiology of photodynamic therapy: Cellular targets and mechanisms. Radiat. Res. 150, S146 S156.
4. Levy, J. G. (1994) Photosensitizers in photodynamic therapy. Semin. Oncol. 21, 4 10.
5. Ibbotson, S. H. (2002) Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br. J. Dermatol. 146, 178 188.
6. Lang, K., P. Lehmann, K. Bolsen, T. Ruzicka C. Fritsch (2001) Aminolevulinic acid: Pharmacological profile and clinical indication. Expert Opin. Investig. Drugs 10, 1139 1156.
7. Szeimies, R. M., M. Landthaler S. Karrer (2002) Non-oncologic indications for ALA-PDT. J. Dermatolog. Treat. 13 (Suppl. 1 S13 S18.
8. Shieh, S., A. S. Dee, R. T. Cheney, N. P. Frawley, N. C. Zeitouni A. R. Oseroff (2002) Photodynamic therapy for the treatment of extramammary Paget's disease. Br. J. Dermatol. 146, 1000 1005.
9. Hopper, C. (2000) Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol. 1, 212 219.
10. Sibata, C. H., V. C. Colussi, N. L. Oleinick T. J. Kinsella (2000) Photodynamic therapy: A new concept in medical treatment. Braz. J. Med. Biol. Res. 33, 869 880.
11. Calzavara-Pinton, P. G., R. M. Szeimies, B. Ortel C. Zane (1996) Photodynamic therapy with systemic administration of photosensitizers in dermatology. J. Photochem. Photobiol. B 36, 225 231.
12. Bissonnette, R., J. F. Tremblay, P. Juzenas, M. Boushira H. Lui (2002) Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J. Invest. Dermatol. 119, 77 83.
13. Gomer, C. J. (1991) Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem. Photobiol. 54, 1093 1107.
14. He, J., H. E. Larkin, Y. S. Li, D. Rihter, S. I. Zaidi, M. A. Rodgers, H. Mukhtar, M. E. Kenney N. L. Oleinick (1997) The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem. Photobiol. 65, 581 586.
15. Anderson, C., S. Hrabovsky, Y. McKinley, K. Tubesing, H. P. Tang, R. Dunbar, H. Mukhtar C. A. Elmets (1997) Phthalocyanine photodynamic therapy: Disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression. Photochem. Photobiol. 65, 895 901.
16. Lam, M., N. L. Oleinick A. L. Nieminen (2001) Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. Reactive oxygen species and mitochondrial inner membrane permeabilization. J. Biol. Chem. 276, 47379 47386.
17. Trivedi, N. S., H. W. Wang, A. L. Nieminen, N. L. Oleinick J. A. Izatt (2000) Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy. Photochem. Photobiol. 71, 634 639.
18. Usuda, J., S. M. Chiu, E. S. Murphy, M. Lam, A. L. Nieminen N. L. Oleinick (2003) Domain-dependent photodamage to Bcl-2. A membrane anchorage region is needed to form the target of phthalocyanine photosensitization. J. Biol. Chem. 278, 2021 2029.
19. Miller, J. D., E. D. Baron, H. Scull, A. Hsia, J. C. Berlin, T. McCormick, V. Colussi, M. E. Kenney, K. D. Cooper N. L. Oleinick (2007) Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The Case experience with preclinical mechanistic and early clinical-translational studies. Toxicol. Appl. Pharmacol. 224, 290 299.
20. Oleinick, N. L., R. L. Morris I. Belichenko (2002) The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 1, 1 21.
21. Edstrom, D. W., A. Porwit A. M. Ros (2001) Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: Clinical and histological response. Acta Derm. Venereol. 81, 184 188.
22. Hunt, D. W. J. G. Levy (1998) Immunomodulatory aspects of photodynamic therapy. Expert Opin. Investig. Drugs 7, 57 64.
23. Jiang, H., D. J. Granville, B. M. McManus, J. G. Levy D. W. Hunt (1999) Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer. Clin. Immunol. 91, 178 187.
24. Jiang, H., D. J. Granville, J. R. North, A. M. Richter D. W. Hunt (2002) Selective action of the photosensitizer QLT0074 on activated human T lymphocytes. Photochem. Photobiol. 76, 224 231.
25. Oleinick, N. L., A. R. Antunez, M. E. Clay, B. D. Rihter M. E. Kenney (1993) New phthalocyanine photosensitizers for photodynamic therapy. Photochem. Photobiol. 57, 242 247.
26. Xue, L. Y., S. M. Chiu N. L. Oleinick (2001) Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 20, 3420 3427.
27. He, J., M. F. Horng, J. T. Deahl, N. L. Oleinick H. H. Evans (1998) Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers. Photochem. Photobiol. 67, 720 728.
28. Xue, L. Y., S. M. Chiu, A. Fiebig, D. W. Andrews N. L. Oleinick (2003) Photodamage to multiple Bcl-xL isoforms by photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 22, 9197 9204.
29. Xue, L. Y., S. M. Chiu N. L. Oleinick (2005) Differential responses of Mcl-1 in photosensitized epithelial vs lymphoid-derived human cancer cells. Oncogene 24, 6987 6992.
30. Michels, J., J. W. O'Neill, C. L. Dallman, A. Mouzakiti, F. Habens, M. Brimmell, K. Y. Zhang, R. W. Craig, E. G. Marcusson, P. W. Johnson G. Packham (2004) Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 23, 4818 4827.
31. Zhou, P., L. Qian, K. M. Kozopas R. W. Craig (1997) Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89, 630 643.
32. Kim, H. R., Y. Luo, G. Li D. Kessel (1999) Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Res. 59, 3429 3432.
33. Kessel, D. M. Castelli (2001) Evidence that bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response. Photochem. Photobiol. 74, 318 322.
34. Usuda, J., K. Azizuddin, S. M. Chiu N. L. Oleinick (2003) Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem. Photobiol. 78, 1 8.